INTERNATIONAL PATENT: IMMUNOCORE LIMITED FILES APPLICATION FOR "TCR-ANTI-CD3 ANTIBODY FUSION MOLECULE FOR THE TREATMENT OF HIV INFECTION"

GENEVA, Feb. 17 -- IMMUNOCORE LIMITED (92 Park Drive, Milton ParkAbingdon Oxfordshire OX14 4RY) filed a patent application (PCT/EP2025/072739) for "TCR-ANTI-CD3 ANTIBODY FUSION MOLECULE FOR THE TREATMENT OF HIV INFECTION" on Aug 07, 2025. With publication no. WO/2026/033067, the details related to the patent application was published on Feb 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DORRELL, Lucy (c/o Immunocore Limited92 Park DriveMilton ParkAbingdon Oxfordshire OX14 4RY), TITANJI, Kehmia (c/o Immunocore Limited92 Park DriveMilton ParkAbingdon Oxfordshire OX14 4RY), SINGH, Praveen ...